?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
News
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
October 26, 2021
Katie Quinn
Biosimilars Forum to Congress: Incentivize Biosimilars in Build Back Better Act
News
October 21, 2021
signalgroup
Biosimilars Forum Member Spotlight: 5 Questions for Samsung Bioepis
News
October 20, 2021
signalgroup
First Biosimilar to Treat Eye Disease Gains FDA Approval
News
October 20, 2021
Katie Quinn
Biosimilars Forum Applauds FDA’s Approval of Second Interchangeable Biosimilar
News
October 13, 2021
Katie Quinn
New Report Finds Biosimilars Could Save States Billions of Dollars Annually
News
September 20, 2021
signalgroup
Senator Wyden, fulfill your promise to lower drug costs for Oregonians by increasing access to next generation generics known as biosimilars
News
September 20, 2021
signalgroup
Senator Carper, fulfill your promise to lower drug costs for Delawareans by increasing access to next generation generics known as biosimilars
News
September 9, 2021
signalgroup
Biden Administration’s Plan to Lower Prescription Drug Prices Supports Biosimilar Competition, which will Decrease Drug Costs
News
August 12, 2021
signalgroup
President Biden’s Plan to Lower Drug Prices Highlights Need for Competition from Biosimilars
News
August 11, 2021
signalgroup
Biosimilars Forum Member Spotlight: 5 Questions for Organon
Prev page
04
05
06
07
08
Next page